The Lattice (Official 3DHEALS Podcast)

3DHEALS
  • 5.0 (2)
  • LIFE SCIENCES
  • UPDATED BIWEEKLY

Welcome to the Lattice podcast, the official podcast for 3DHEALS. This is where you will find fun but in-depth conversations (by founder Jenny Chen) with technological game-changers, creative minds, entrepreneurs, rule-breakers, and more. The conversations focus on using 3D technologies, like 3D printing and bioprinting, AR/VR, and in silico simulation, to reinvent healthcare and life sciences. This podcast will include AMA (Ask Me Anything) sessions, interviews, select past virtual event recordings, and other direct engagements with our Tribe.While there is no rule for our podcast content, the only rule we follow is to provide our listeners with a maximized return on their attention and time investment.Follow us on Facebook, Twitter, and Instagram @3dheals, and check out the links in the show notes. 3DHEALS Links: https://linktr.ee/3dheals 🛑 Disclaimer The content of this podcast is for informational and educational purposes only and does not constitute medical, legal, or financial advice. The views and opinions expressed by the host and guests are their own and do not necessarily reflect those of their employers, affiliates, or any associated organizations. While we discuss emerging technologies in healthcare and 3D printing, listeners should consult qualified professionals before making decisions based on the information shared. The mention of specific companies, products, or technologies does not imply endorsement. This podcast may reference early-stage innovations and concepts that are not yet FDA-approved or commercially available. Always follow regulatory guidelines and ethical standards when applying new technologies in clinical or professional settings.

  1. Episode #111| Bench to Bedside: Bioprinting Innovation Virtual Event Recording

    4D AGO

    Episode #111| Bench to Bedside: Bioprinting Innovation Virtual Event Recording

    Everyone talks about printing organs, but the closest thing to real impact often starts with something less flashy and far more practical: the materials. We bring together founders and operators working across bioprinted implants, structural bone substitutes, cryopreserved tissue models, and natural biopolymer manufacturing to answer one question that matters: what actually makes advanced biofabrication translate from bench to bedside? We dig into bone regeneration and why scaffolds fail when they can’t balance strength, vascular support, and predictable resorption. You’ll hear how absorbable polyurethane platforms aim to avoid acidic degradation while letting teams program mechanics and timelines, plus how 3D printed beta-tricalcium phosphate ceramics can deliver structural consistency and then remodel into native bone. The conversation stays grounded in the realities that decide adoption: predicates and evidence expectations for FDA 510(k), the heavier burden of EU MDR, and the uncomfortable truth that clearance doesn’t guarantee reimbursement. Then we shift to new approach methodologies for drug development, where cryobioprinting tackles the biggest blocker in bioprinted tissues: logistics. If tissues can be frozen, inventoried, shipped, and used on demand, bioprinting becomes a consumable workflow instead of an artisanal one-off. We close with a candid translation playbook for natural biopolymers and a high-volume pediatric use case: dissolvable chitosan ear tubes designed to reduce repeat surgeries, plus the pricing and coverage strategy needed to make that upgrade viable. Subscribe, share this with a builder in medtech or biotech, and leave a review with your biggest takeaway: which bottleneck matters most right now, materials, regulation, reimbursement, or scale-up? Event link: https://3dheals.com/bench-to-bedside-bioprinting-innovations/ YouTube highlights: Stay tuned Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    1h 49m
  2. Episode #110 | Neurotech Investing With Varun Turlapati, Chaanakya Capital

    4D AGO

    Episode #110 | Neurotech Investing With Varun Turlapati, Chaanakya Capital

    Neurotech is the category most investors whisper about and then walk away from: too technical, too regulated, too slow. We wanted to talk to someone who leans in anyway, so I sat down with Varun Turlapati, founder of Chanakya Capital, to hear how he’s building an early-stage fund dedicated to neurotech devices and why he thinks the “long horizon” objection often misses what’s actually happening on the ground. We unpack Varun’s path from software engineering into venture capital, including the mindset shift from analysis paralysis to fast iteration with smart guardrails. From there, we widen the frame on what neurotech means. Yes, brain-computer interfaces matter, but we also get into neuromodulation, bioelectronics, and the nervous system as the body’s command network, linking the brain, gut, and heart, and addressing disease. That lens turns “niche” into “everyone with a brain,” and it changes how you think about markets, clinical impact, and investable product strategy. Varun also shares the practical mechanics of deep tech investing: how he triages an 80+ company pipeline, separates “interesting” from “investable,” and brings in PhD scientists, physicians, and specialist advisors to evaluate clinical workflows and real differentiation. We dive into real examples across neuroprosthetics, Alzheimer’s, ADHD, and autism wearables, and a smart shunt for hydrocephalus, plus how regulatory signals like Breakthrough Device Designation can reshape the risk profile. If you care about neurotech startups, medical devices, FDA pathways, or where venture capital goes after AI becomes commoditized, this conversation will sharpen your evaluation of both science and execution. Subscribe to Lattice, share this with a founder or investor who’s curious about neurotech, and leave a review with the biggest question you still have about building in this space. Show notes: coming soon YouTube recording: coming soon Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    1h 2m
  3. Episode #109| March Newsletter: From Bioprinted Organs To FDA Cleared Implants In Healthcare 3D Printing

    MAR 29

    Episode #109| March Newsletter: From Bioprinted Organs To FDA Cleared Implants In Healthcare 3D Printing

    We track the biggest healthcare 3D printing stories from March 2026, from bioprinted organs and sustainable bioinks to FDA-cleared implants and hospital point-of-care wins. We also look at how 3D printed cancer tools, training models, microrobots, and AI quality control are moving from research into real clinical and manufacturing workflows.  • bioprinted uterus model for preterm labor drug testing and future personalization  • ENLIGHT pancreas project using volumetric bioprinting and long viability gels for diabetes research  • vascularized adipose tissue implants for soft tissue repair and breast reconstruction  • Singapore biofabrication roadmap focused on sustainable biomaterials and circular supply chains  • FDA 510(k) cleared titanium spinal implant plus trends in lumbar cage materials and coatings  • EU MDR certified denture manufacturing and implications for scaled dental 3D printing  • 3D printed breast cancer locator improving surgical margins with patient-specific guides  • 3D printed metastasis research platform showing fibroblast protection in blood flow stress  • brain phantoms and beating heart simulators for realistic surgical training  • bioprinted cardiac spheroids for studying SARS-CoV-2 heart infection and drug testing  • microrobots, AI defect prediction, volumetric production methods, and micro-scale printers  • hospital-made rehab devices cutting costs and a reality check on AI-driven implants  Please subscribe for more future updates and let us know if anything is missing or incorrect.  Complete show notes, including links to all articles mentioned in this podcast, are here.  Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    11 min
  4. Episode #108 | Teleporting Medicine with 3D Printing - Dr. Stephen Ryan, PolyUnity

    MAR 14

    Episode #108 | Teleporting Medicine with 3D Printing - Dr. Stephen Ryan, PolyUnity

    What happens when a hospital needs a simple part but the supply chain takes weeks or months to deliver it? Dr. Stephan Ryan, physician and co-founder of PolyUnity, set out to solve that problem by helping hospitals produce parts themselves through safe, compliant 3D printing. In this episode, Stephen Ryan shares how early clinical experiences and an academic 3D printing lab evolved into a platform designed to help hospitals manufacture equipment on demand. The COVID pandemic accelerated that vision, exposing major supply chain gaps and pushing the team to rapidly scale production. Stephen Ryan explains how those lessons shaped PolyUnity’s approach to building practical additive manufacturing systems within the realities of healthcare procurement, regulation, and hospital workflows. Bullet points: • Defining PolyUnity’s mission to democratize hospital 3D printing with compliant workflows • The rural hospital supply chain problem that sparked the original research project • How COVID accelerated real-world production and forced end-to-end process design • Why post-pandemic red tape returned and how it shaped the software moat • Bootstrapping a medtech startup in Canada with long procurement cycles • Building a small team and staying capital efficient through iterative deployment • Good and "bad" ideas for hospital 3D printing applications • High-ROI case applications that avoid big spend • Distributed manufacturing hubs and the practical path toward on-site production • The wisdom of choosing simple over complexity. • Post-processing bottlenecks and what are potential solutions. • Personal transformation from clinician to entrepreneur.   Show notes: https://3dheals.com/teleporting-medicine-with-3d-printing-dr-stephen-ryan-of-polyunity-interview/ Full video interview: https://youtu.be/cO7mTr5GLJ8?si=icmU03OI1cPDZJL9 About our guest:  Dr. Stephen Ryan is a physician, entrepreneur, and the co-founder and Chief Medical Officer of PolyUnity, a Canadian health tech company focused on lowering the barrier for hospitals to adopt 3D printing through its i3D platform and solutions. His work centers on building software, quality systems, and distributed print capacity so that hospitals can reliably order and receive end use 3D printed parts, from simple fixtures to clinically relevant devices, within existing procurement and regulatory frameworks. Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    56 min
  5. Episode#107 | The Lattice Feb 2026 - Latest News in Healthcare 3D Printing

    FEB 23

    Episode#107 | The Lattice Feb 2026 - Latest News in Healthcare 3D Printing

    We map the biggest shifts in healthcare 3D printing this month, from emissions safety to custom eyewear, implant surfaces, microfluidics, and space-based biomanufacturing. We weigh promise against risk and share where standards and design can close the gap. • emissions from desktop and industrial printers and why they matter  • safeguards for vulnerable groups and safer materials and testing  • face-scan eyewear, on-demand manufacturing, and fashion collaborations  • implant surface roughness, porosity, coatings, and clinical outcomes  • ceramic, titanium, and PEEK devices for spine, ankle, and CMF  • microfluidics for diagnostics and microneedle vaccines and immunotherapy  • digital microfluidics and 3D cell culture for faster R&D  • microgravity biomanufacturing and what space enables for medicine See blog post related to this podcast: https://3dheals.com/the-lattice-feb-2026-advanced-devices-custom-eyewear-and-hidden-health-risks-of-3d-printing/ Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    7 min
  6. Episode #106| Bionic Hands For Humans and Robots: The Psyonic Story

    FEB 22

    Episode #106| Bionic Hands For Humans and Robots: The Psyonic Story

    We share how a decade of soft robotics, open APIs, and relentless iteration turned a 3D-printed prototype into a durable, touch-sensing bionic hand used by amputees and robots. Stories of failure, funding, and firsts reveal how speed, sensation, and design choices translate to real lives and real factories. • early 3D printing wins and durability limits • shift to soft robotics, silicone overmolding, carbon fiber reinforcement • founding spark, Ecuador trial, and move from academia to company • SBIR lifeline, failed crowdfunding, then coverage and clinical validation • speed, grip force, and touch sensors compared with the market • open API for control and data streaming in minutes • robotics crossover in automotive and research labs • access initiatives via the Ability Fund and global impact • manufacturing scale plans and ethical boundaries • practical founder habits, grit, and advice to start now Please listen to the disclaimer at the end of this podcast Show notes: https://3dheals.com/aadeel-akhtar-bionic-hands-for-humans-and-robots-the-psyonic-story/ YouTube: https://youtu.be/mDVMRhjXr0w?si=qoZrScjaC6nbiPMJ About our guest: Dr. Aadeel Akhtar, CEO of PSYONIC, founded the company to create advanced, accessible bionic limbs after meeting a young girl in Pakistan who was missing a limb. PSYONIC's bionic Ability Hand is the fastest on the market, impact-resistant, and the first to provide a sense of touch. It is also covered by Medicare and is being used by humans and robotics companies globally, including NASA, Meta, Mercedes, and Google. Dr. Akhtar earned a Ph.D. in Neuroscience and an M.S. in Electrical & Computer Engineering from the University of Illinois, along with a B.S. in Biology and an M.S. in Computer Science from Loyola University Chicago. He’s been recognized by MIT Technology Review and Newsweek and secured a 3-shark deal on Shark Tank.  Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    54 min
  7. Episode #105 | Jan 2026 News: ARPA-H Organ "Moonshots", Point-of-Care Manufacturing, and More

    JAN 26

    Episode #105 | Jan 2026 News: ARPA-H Organ "Moonshots", Point-of-Care Manufacturing, and More

    We track a month of fast-moving news in healthcare 3D printing, from organ-scale bioprinting programs and ARPA-H’s funding model to point-of-care tools already entering clinics. The throughline is clear: vascularization, immune compatibility, and scale are converging with real-world deployment. • UT Southwestern’s organoid-plus-bioprinting strategy for durable liver tissue • Carnegie Mellon’s consortium on vascularization, immune control, and scale • ARPA-H’s moonshot funding model is accelerating medical innovation • Aspect Biosystems and Novo Nordisk’s bet on curing diabetes • Cost shift from chronic management to curative therapies • Near-term point-of-care printing: Curify Labs and AZORG integrations • Key milestone to watch: functional vascular networks • Outlook as research, industry, and funding align Remember, this podcast is for educational and informational purposes only The views expressed do not constitute engineering, medical, or financial advice. The technologies and procedures discussed may not be commercially available or suitable for every case. Always consult with a qualified professional Shownotes: https://3dheals.com/lattice-news-arpa-h-organ-moonshots-point-of-care-manufacturing-and-more/ Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    5 min
  8. Episode #104| 3DHEALS2026 JP Morgan San Francisco (Live Recording) - Invest in 3D

    JAN 17

    Episode #104| 3DHEALS2026 JP Morgan San Francisco (Live Recording) - Invest in 3D

    A crowded JP Morgan week can blur into noise, so we built a quieter stage to focus on what actually moves healthcare forward: 3D software‑planned care, on‑demand manufacturing, and proof that patients and payers can feel. Recorded live in San Francisco, this special episode brings founders and investors together to show how 3D data and advanced manufacturing are turning personalization into a scalable, measurable reality. We start with a rare blueprint for value in spine surgery: virtual planning, patient‑specific 3D printed implants, and post‑op analytics that cut two‑year reoperations by 74% while compressing lead times from eight weeks to eight days. From there, the conversation widens fast. Hear how microarray patches with five‑micron precision enable co‑delivery without co‑formulation and factory‑level scale; how therapeutic hardware draws on bone biology to reduce revisions; how personalized pessaries bring dental‑style business models to women’s health; and how drill‑free, patient‑specific dental implants fit in six days without a single turn of a drill. We also explore the frontier where human recovery meets robotics. A single bionic hand platform serves amputees and humanoid robots, translating human manipulation data into industrial automation while staying Medicare‑covered. On the R&D side, vascularized tissues and cryobioprinted models aim to fix translational failure by making complex biology reproducible and shippable. Structural biopolymer fibers unlock sutures, meshes, and sports medicine implants with clean‑room scale. A countertop system automates cell therapy final formulation so community hospitals can treat more patients safely. And a new biomanufacturing approach targets IVIG supply constraints by achieving human‑like B‑cell densities in ultrafast 3D printed bioreactors. We close with high‑viscosity inkjet that prints materials traditional jets can’t, powering durable dental parts and microneedle patches at true production speeds. Along the way, an investor panel compares notes on 2026: where exits might return, where non‑dilutive capital is shifting, and what it now takes to earn a check—clear end‑user value, defensible tech, and a distribution edge. If you care about medtech, bioprinting, cell and gene therapy delivery, or the future of personalized care, this is your field guide to what’s working right now. If this conversation sparks new ideas or a partnership you want to pursue, subscribe, share the episode with a colleague, and leave a quick review telling us which breakthrough you want to hear more about. Event speaker biographies: https://3dheals.com/life-in-3d-investing-in-the-next-frontier/ On-Demand Video (Pending publication): https://3dheals.com/courses/ Pitch 3D Application link: https://3dheals.com/pitch3d/ Send us Fan Mail Support the show Subscribe to our premium version and support the show.  Follow us: Twitter  Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D

    2h 10m
See All (39)

Ratings & Reviews

5
out of 5
2 Ratings

About

Welcome to the Lattice podcast, the official podcast for 3DHEALS. This is where you will find fun but in-depth conversations (by founder Jenny Chen) with technological game-changers, creative minds, entrepreneurs, rule-breakers, and more. The conversations focus on using 3D technologies, like 3D printing and bioprinting, AR/VR, and in silico simulation, to reinvent healthcare and life sciences. This podcast will include AMA (Ask Me Anything) sessions, interviews, select past virtual event recordings, and other direct engagements with our Tribe.While there is no rule for our podcast content, the only rule we follow is to provide our listeners with a maximized return on their attention and time investment.Follow us on Facebook, Twitter, and Instagram @3dheals, and check out the links in the show notes. 3DHEALS Links: https://linktr.ee/3dheals 🛑 Disclaimer The content of this podcast is for informational and educational purposes only and does not constitute medical, legal, or financial advice. The views and opinions expressed by the host and guests are their own and do not necessarily reflect those of their employers, affiliates, or any associated organizations. While we discuss emerging technologies in healthcare and 3D printing, listeners should consult qualified professionals before making decisions based on the information shared. The mention of specific companies, products, or technologies does not imply endorsement. This podcast may reference early-stage innovations and concepts that are not yet FDA-approved or commercially available. Always follow regulatory guidelines and ethical standards when applying new technologies in clinical or professional settings.

Information